Connection

Anand Mehta to Biomarkers, Tumor

This is a "connection" page, showing publications Anand Mehta has written about Biomarkers, Tumor.
Connection Strength

3.203
  1. Biomarker analysis of fucosylated kininogen through depletion of lectin reactive heterophilic antibodies in hepatocellular carcinoma. J Immunol Methods. 2018 11; 462:59-64.
    View in: PubMed
    Score: 0.482
  2. The search for biomarkers of hepatocellular carcinoma and the impact on patient outcome. Curr Opin Pharmacol. 2018 08; 41:74-78.
    View in: PubMed
    Score: 0.473
  3. Identification of fucosylated Fetuin-A as a potential biomarker for cholangiocarcinoma. Proteomics Clin Appl. 2017 09; 11(9-10).
    View in: PubMed
    Score: 0.446
  4. Changes in the Glycosylation of Kininogen and the Development of a Kininogen-Based Algorithm for the Early Detection of HCC. Cancer Epidemiol Biomarkers Prev. 2017 05; 26(5):795-803.
    View in: PubMed
    Score: 0.434
  5. Novel fucosylated biomarkers for the early detection of hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev. 2009 Jun; 18(6):1914-21.
    View in: PubMed
    Score: 0.254
  6. Identification and development of fucosylated glycoproteins as biomarkers of primary hepatocellular carcinoma. J Proteome Res. 2009 Feb; 8(2):595-602.
    View in: PubMed
    Score: 0.248
  7. Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma. J Proteome Res. 2006 Feb; 5(2):308-15.
    View in: PubMed
    Score: 0.202
  8. Beyond glyco-proteomics-Understanding the role of genetics in cancer biomarkers. Adv Cancer Res. 2023; 157:57-81.
    View in: PubMed
    Score: 0.160
  9. Imaging Mass Spectrometry and Lectin Analysis of N-Linked Glycans in Carbohydrate Antigen-Defined Pancreatic Cancer Tissues. Mol Cell Proteomics. 2021; 20:100012.
    View in: PubMed
    Score: 0.141
  10. Biomarkers for the Early Detection of Hepatocellular Carcinoma. Cancer Epidemiol Biomarkers Prev. 2020 12; 29(12):2495-2503.
    View in: PubMed
    Score: 0.135
  11. Interleukin-6 and oncostatin M are elevated in liver disease in conjunction with candidate hepatocellular carcinoma biomarker GP73. Cancer Biomark. 2012; 11(4):161-71.
    View in: PubMed
    Score: 0.076
  12. Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. Proc Natl Acad Sci U S A. 2005 Jan 18; 102(3):779-84.
    View in: PubMed
    Score: 0.047
  13. Nuclear PFKP promotes CXCR4-dependent infiltration by T cell acute lymphoblastic leukemia. J Clin Invest. 2021 08 16; 131(16).
    View in: PubMed
    Score: 0.037
  14. Glycan Imaging Mass Spectrometry: Progress in Developing Clinical Diagnostic Assays for Tissues, Biofluids, and Cells. Clin Lab Med. 2021 06; 41(2):247-266.
    View in: PubMed
    Score: 0.036
  15. Hepatocellular carcinoma of the liver. Cancer Biomark. 2010; 9(1-6):375-83.
    View in: PubMed
    Score: 0.017
  16. Glycomic characterization of prostate-specific antigen and prostatic acid phosphatase in prostate cancer and benign disease seminal plasma fluids. J Proteome Res. 2009 Feb; 8(2):620-30.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.